Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 25 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 800,000 | 0.00 | 2,687,118 |
31 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.56 | 110,750 | 394.27 k | 1,887,118 |
31 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.56 | 110,750 | 394.27 k | 1,997,868 |
31 Jan 25 | XERS Xeris Biopharma | Stock Appreciation Right Common Stock | Grant | Acquire A | No | No | 3.56 | 600,000 | 2.14 mm | 600,000 |
3 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 39,443 | 142.39 k | 2,108,618 |
31 Jan 24 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 750,000 | 0.00 | 2,158,575 |
17 Nov 23 | XERS Xeris Biopharma | Common Stock | Buy | Acquire P | No | No | 1.638 | 30,769 | 50.40 k | 1,408,575 |